Linopirdine
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Pharmacological Modulation of the Voltage-Gated Neuronal Kv7/KCNQ
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Identification of a Novel Potassium Channel
- Facilitation of Transmitter Release from Rat Sympathetic Neurons Via Presynaptic
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Ion Channel Pharmacology
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Non-Lipid Benzofuran Ethanolamine Structures
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
- NIH Public Access Author Manuscript Nat Rev Drug Discov
- (12) Patent Application Publication (10) Pub. No.: US 2011/0065628A1 Johnson Et Al
- Customs Tariff - Schedule Xxi - 1
- Inhibition of Voltage-Dependent K+ Current in Rabbit Coronary Arterial
- Cholinergic Suppression of KCNQ Channel Currents Enhances Excitability of Striatal Medium Spiny Neurons
- Wo 2007/044693 A2
- New Molecular Targets for Antiepileptic Drugs: Α2δ, SV2A and Kv7/KCNQ/M Potassium Channels
- (12) United States Patent (10) Patent No.: US 9,017,735 B2 Ghasemzadeh (45) Date of Patent: Apr
- Molecular Similarity Within the Melatonin Structure
- Harmonized Tariff Schedule of the United States (2006) (Rev